# Vaxcyte, Inc.: Form 8-K, filed Dec 19, 2025

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2025-12-19
- Accepted by EDGAR: Dec 19, 2025, 16:11 ET
- Period: 2025-12-18
- Accession: 0001649094-25-000116
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/pcvx-20251218.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000164909425000116/pcvx-20251218.htm

Filed Dec 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001649094-25-000116. Last ingested by Listed: Nov 6, 2026, 13:09 ET. No prices; not investment advice.